S 689
A bill to amend the Controlled Substances Act to define currently accepted medical use with severe restrictions, and for other purposes.
Jurisdiction
US Congress
Session
118th Congress (2023-2024)
Last updated at
Jun 16, 2026, 6:20 PM
Take action
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed Senate
- Passed House
- To President
- Became Law
Bill overview
This bill provides for the classification of drugs or other substances that are part of approved breakthrough therapies as schedule II controlled substances under the Controlled Substances Act. (Schedule II controlled substances are substances that have a high potential for abuse but have a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions.)
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Kyrsten Sinema
Mike Braun
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.